View More Recent Stories
-
Incyte (INCY) Misses Q2 EPS by 269c; raises guidance
-
Incyte (INCY) PT Lowered to $81 at Oppenheimer
-
BMO Capital Downgrades Incyte (INCY) to Underperform
-
Incyte (INCY) Announces Final Results of Tender Offer
-
Incyte (INCY) Announces Preliminary Results of Tender Offer
-
Increasing unusual option volume: SANA FFIE INCY MBLY CRDO OPRA EFA DM IMVT
-
4 Buy-rated Healthcare stocks with 30-45% upside

